Cornelis Kluft

Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products.

T. Kooistra, V. V. van Hinsbergh, G. Dooijewaard, 1990, Blood.

Pharmacokinetics of antigen and activity of recombinant tissue-type plasminogen activator after infusion in healthy volunteers.

E. Seifried, C. Kluft, D. Rijken, 1988, Arzneimittel-Forschung.

Pharmacokinetics of Saruplase, a Recombinant Unglycosylated Human Single-Chain Urokinase-Type Plasminogen Activator and Its Effects on Fibrinolytic and Haemostatic Parameters in Healthy Male Subjects

G. Dooijewaard, A. Cohen, C. Kluft, 1993, Thrombosis and Haemostasis.

Effects of Moderate Alcohol Consumption on Platelet Function, Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor

T. Ockhuizen, G. Schaafsma, C. Kluft, 1990, Thrombosis and Haemostasis.